Jennifer J Schneider (Jennifer Schneider)

Scopus Author ID Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 14

Top Venues

Pharmacy (Basel, Switzerland)

British journal of clinical pharmacology

Pharmaceuticals (Basel, Switzerland)

Pharmacology research & perspectives

University of Newcastle

This page only lists publications with an associated author ORCID identifier.

Affiliation History

University of Newcastle Jul 31 2003

Australia

Associate Professor :: School of Medicine and Public Health

Publications

Fern Beschi, Rachel Hughes, Jennifer J Schneider
Administration of Levetiracetam via Subcutaneous Infusion for Seizure Control in the Palliative Care Setting: A Narrative Review. Pharmacy (Basel, Switzerland) 12 (4) (2024)
Fern Beschi, Rachel Hughes, Jennifer J Schneider
Administration of Levetiracetam via Subcutaneous Infusion for Seizure Control in the Palliative Care Setting: A Narrative Review. Pharmacy (Basel, Switzerland) 12 (4) (2024)
Fern Beschi, Rachel Hughes, Jennifer J Schneider
Administration of Levetiracetam via Subcutaneous Infusion for Seizure Control in the Palliative Care Setting: A Narrative Review. Pharmacy (Basel, Switzerland) 12 (4) (2024)
Jennifer H Martin, Peter Galettis, Alex Flynn, Jennifer J Schneider
Phenotype versus genotype to optimize cancer dosing in the clinical setting-focus on 5-fluorouracil and tyrosine kinase inhibitors. Pharmacology research & perspectives 12 (2) (2024)
Mirjana Radovanovic, Peter Galettis, Alex Flynn, Jennifer H Martin, Jennifer J Schneider
Paclitaxel and Therapeutic Drug Monitoring with Microsampling in Clinical Practice. Pharmaceuticals (Basel, Switzerland) 17 (1) (2023)
Mirjana Radovanovic, Peter Galettis, Alex Flynn, Jennifer H Martin, Jennifer J Schneider
Paclitaxel and Therapeutic Drug Monitoring with Microsampling in Clinical Practice. Pharmaceuticals (Basel, Switzerland) 17 (1) (2023)
Mirjana Radovanovic, Peter Galettis, Alex Flynn, Jennifer H Martin, Jennifer J Schneider
Paclitaxel and Therapeutic Drug Monitoring with Microsampling in Clinical Practice. Pharmaceuticals (Basel, Switzerland) 17 (1) (2023)
Paul Ken Leong Chin, Kellie Charles, Bridin Murnion, Treasure M McGuire, Sarah Nicole Hilmer, Jennifer Martin, David Reith, David Joyce, Catherine J Lucas, Nick H G Holford, Richard Osborne Day, Jennifer J Schneider, Matthew Doogue, Catherine H Han, Sarah Herd, Claire Harrison, Deborah O'Mara
Evaluation of the Prescribing Skills Assessment implementation, performance and medical student experience in Australia and New Zealand. British journal of clinical pharmacology (2023)
Mirjana Radovanovic, Peter Galettis, Alex Flynn, Jennifer H Martin, Jennifer J Schneider
Paclitaxel and Therapeutic Drug Monitoring with Microsampling in Clinical Practice. Pharmaceuticals (Basel, Switzerland) 17 (1) (2023)
Daniel Asfaw Erku, Jennifer J Schneider, Paul A Scuffham
A framework for economic evaluation of therapeutic drug monitoring-guided dosing in oncology. Pharmacology research & perspectives 9 (5) (2022)
Jennifer J Schneider, Chelsea Felkai, Irene Munro
A Comparison of Real and Virtual Laboratories for Pharmacy Teaching. Pharmacy (Basel, Switzerland) 10 (5) (2022)
Jennifer J Schneider, Peter Galettis, Jennifer H Martin
Overcoming barriers to implementing precision dosing with 5-fluorouracil and capecitabine. British journal of clinical pharmacology 87 (2) (2021)
Catherine J Lucas, Peter Galettis, Jennifer J Schneider
The pharmacokinetics and the pharmacodynamics of cannabinoids. British journal of clinical pharmacology 84 (11) (2018)
Laura M Dryburgh, Nanthi S Bolan, Christopher P L Grof, Peter Galettis, Jennifer J Schneider, Catherine J Lucas, Jennifer H Martin
Cannabis contaminants: sources, distribution, human toxicity and pharmacologic effects. British journal of clinical pharmacology 84 (11) (2018)

Jennifer J Schneider.css-eqlu8i{font-size:small;padding-left:4px;} (Jennifer Schneider)

Publication Activity (10 Years)

Top Topics

Top Venues

Jennifer J Schneider (Jennifer Schneider)